The University of Chicago Header Logo

Connection

Richard Quigg to Mice, Inbred MRL lpr

This is a "connection" page, showing publications Richard Quigg has written about Mice, Inbred MRL lpr.
Connection Strength

0.805
  1. Complement factor H deficiency accelerates development of lupus nephritis. J Am Soc Nephrol. 2011 Feb; 22(2):285-95.
    View in: PubMed
    Score: 0.094
  2. Alteration in kidney glucose and amino acids are implicated in renal pathology in MRL/lpr mice. Biochim Biophys Acta. 2007 Oct; 1772(10):1143-9.
    View in: PubMed
    Score: 0.075
  3. Absence of functional alternative complement pathway alleviates lupus cerebritis. Eur J Immunol. 2007 Jun; 37(6):1691-701.
    View in: PubMed
    Score: 0.074
  4. Complement-dependent apoptosis and inflammatory gene changes in murine lupus cerebritis. J Immunol. 2005 Dec 15; 175(12):8312-9.
    View in: PubMed
    Score: 0.067
  5. Signaling through up-regulated C3a receptor is key to the development of experimental lupus nephritis. J Immunol. 2005 Aug 01; 175(3):1947-55.
    View in: PubMed
    Score: 0.065
  6. C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist. Eur J Immunol. 2005 Aug; 35(8):2496-506.
    View in: PubMed
    Score: 0.065
  7. Administration of the soluble complement inhibitor, Crry-Ig, reduces inflammation and aquaporin 4 expression in lupus cerebritis. Biochim Biophys Acta. 2003 Nov 20; 1639(3):169-76.
    View in: PubMed
    Score: 0.058
  8. Excessive matrix accumulation in the kidneys of MRL/lpr lupus mice is dependent on complement activation. J Am Soc Nephrol. 2003 Oct; 14(10):2516-25.
    View in: PubMed
    Score: 0.057
  9. Administration of a soluble recombinant complement C3 inhibitor protects against renal disease in MRL/lpr mice. J Am Soc Nephrol. 2003 Mar; 14(3):670-9.
    View in: PubMed
    Score: 0.055
  10. Transgenic expression of a soluble complement inhibitor protects against renal disease and promotes survival in MRL/lpr mice. J Immunol. 2002 Apr 01; 168(7):3601-7.
    View in: PubMed
    Score: 0.052
  11. C5a induces caspase-dependent apoptosis in brain vascular endothelial cells in experimental lupus. Immunology. 2016 08; 148(4):407-19.
    View in: PubMed
    Score: 0.035
  12. Curcumin aggravates CNS pathology in experimental systemic lupus erythematosus. Brain Res. 2013 Apr 04; 1504:85-96.
    View in: PubMed
    Score: 0.027
  13. Inhibition of C5a receptor alleviates experimental CNS lupus. J Neuroimmunol. 2010 Apr 15; 221(1-2):46-52.
    View in: PubMed
    Score: 0.022
  14. C5a alters blood-brain barrier integrity in experimental lupus. FASEB J. 2010 Jun; 24(6):1682-8.
    View in: PubMed
    Score: 0.022
  15. C3aR inhibition reduces neurodegeneration in experimental lupus. Lupus. 2010 Jan; 19(1):73-82.
    View in: PubMed
    Score: 0.022
  16. CR1/CR2 deficiency alters IgG3 autoantibody production and IgA glomerular deposition in the MRL/lpr model of SLE. Autoimmunity. 2004 Mar; 37(2):111-23.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.